Norcantharidin enhances antitumor immunity of GM‐CSF prostate cancer cells vaccine by inducing apoptosis of regulatory T cells

Norcantharidin (NCTD) is a promising antitumor drug with low toxicity. It was reported to be able to regulate immunity, but the mechanism is not yet clear. Here we explored whether NCTD could enhance the antitumor immunity induced by prostate cancer cell vaccine. The results of the in vitro study sh...

Descripción completa

Detalles Bibliográficos
Autores principales: Mo, Lijun, Zhang, Xinji, Shi, Xiaojun, Wei, Lili, Zheng, Dianpeng, Li, Hongwei, Gao, Jimin, Li, Jinlong, Hu, Zhiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029826/
https://www.ncbi.nlm.nih.gov/pubmed/29770533
http://dx.doi.org/10.1111/cas.13639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029826/
https://www.ncbi.nlm.nih.gov/pubmed/29770533
http://dx.doi.org/10.1111/cas.13639

Ejemplares similares